NM-ADTRAN
28.2.2024 14:01:33 CET | Business Wire | Press release
Adtran today announced that Mescalero Apache Telecom, Inc. (MATI) is harnessing its fiber access solution to bring high-speed connectivity to rural tribal communities in New Mexico. Supported by a mix of loans and grant funds, MATI’s new infrastructure is the first full FTTH XGS-PON network to be built among any tribal nation. Part of the Broadband Infrastructure Deployment initiative, the solution will deliver symmetrical Gigabit services to the Mescalero Apache reservation. The deployment is set to have a significant impact on the community, empowering residents with access to critical online resources such as education, telehealth services and remote work opportunities. Key components of the new network include Adtran’s AI-driven Mosaic One Device Manager and its Oscilloquartz timing and synchronization technology. Adtran’s partner, Netceed, a leading provider of materials, distribution and supply chain management solutions supporting the telecommunications and broadband industry, is also playing a key role in the project.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240228081531/en/
Mescalero Apache Telecom, Inc. is using Adtran’s technology to deliver high-speed broadband services to tribal communities in New Mexico. (Photo: Business Wire)
“Building high-quality internet infrastructure is one of the most effective ways of improving life in tribal communities. That’s why, as part of the award we’ve received to help close the digital divide in New Mexico, we’re connecting 29 community anchor institutions, including libraries and Head Start centers, to our new symmetrical Gigabit services,” said Godfrey Enjady, GM of MATI. “As our trusted and longstanding partner, it’s great to have Adtran by our side as we roll out the first FTTH tribal network using XGS-PON technology. By leveraging their innovation, we’re expanding and enhancing our network with a flexible, scalable platform primed to address today’s connectivity challenges and ready to support tomorrow’s multigigabit demands.”
Adtran’s technology is empowering MATI to seamlessly transition to an XGS-PON network that provides full-fiber and fixed wireless access connectivity. The Total Access 5000 lays the foundations for a robust infrastructure, while Mosaic One streamlines network operations and subscriber device management for efficient, customer-centric service delivery. Adtran’s ONTs are supplying high-speed internet to 835 previously unserved households and 336 business premises. Featuring a 10GbE interface, the compact and powerful devices are also capable of providing premium multigigabit services. For enhanced in-home coverage, Adtran’s high-performance mesh routers deliver extensive and reliable connectivity. And with the precision of Adtran’s Oscilloquartz synchronization technology, the solution ensures a seamless and robust experience for new and existing subscribers.
“We’re proud to support MATI in its mission. What we all share is a commitment to fostering digital inclusivity. It’s crucial that tribal communities are not just connected but also fully equipped with the reliable, high-quality tools and resources necessary to thrive in an increasingly digital world,” commented John Scherzinger, GM of Americas sales at Adtran. “By leveraging our broadband solutions and the dedicated support of the Adtran and Netceed team, MATI is enriching lives and creating new opportunities for learning, growth and development. It’s enabling these previously underserved communities to make digital access a foundational element of their growth and success.”
“At Netceed, a large part of our mission involves connecting the unconnected. As a one-stop shop distribution and solutions partner to our customers, we strive to push the boundaries of technology, helping ensure universal access to digital opportunities,” noted Chet Enos, senior director of sales, south central at Netceed. “The deployment of Adtran’s open and scalable fiber access solution marks a significant advancement for these communities. Working closely together, we’ve been able to equip MATI’s subscribers with the high-quality, ultra-fast broadband they deserve. It’s vital that New Mexico’s rural tribal homes and businesses have affordable access to the same information and resources available in other areas of the country. With its new network, MATI is paving the way for people living in remote regions to benefit from a more connected and prosperous future, and we’re proud to be part of this initiative.”
Further information on how Adtran is helping MATI and its communities is available in this video.
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
Published by
ADTRAN Holdings, Inc.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240228081531/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From AI to Autonomous Networks: Mobileum Spark Highlights the Next Frontier of Telecom Intelligence15.10.2026 09:00:00 CEST | Press release
Industry leaders get together to explore how trusted AI, Agentic Intelligence and automation are transforming risk management, accelerating autonomous network operations and unlocking new opportunities for value creation Mobileum Inc. ("Mobileum"), a leading global provider of telecom analytics and network solutions, brought together telecom operators and industry leaders during its Mobileum Spark events series in Lisbon (Portugal) and Frankfurt (Germany), to explore how Artificial Intelligence (AI), Agentic AI and automation are transforming network operations and accelerating the evolution toward autonomous networks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015172815/en/ Telecom operators, industry leaders, and Mobileum experts at Mobileum Spark 2026. Focused on Risk Management & Fraud Prevention and Network Testing & Assurance, the events featured customer-led discussions, expert insights, and real-world use case
Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention15.10.2026 08:00:00 CEST | Press release
Patient recruitment completed six months ahead of schedule in two global Phase III trials for migraine prevention MINT-E and MINT-C are evaluating XEOMIN® (incobotulinumtoxinA) for the preventive treatment of episodic and chronic migraine Trials recruited approximately 1,800 adults across 109 study sites in North America and Europe Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the completion of patient recruitment in two global Phase III clinical trials, MINT-E (NCT07018700) and MINT-C (NCT07018713), evaluating the efficacy and safety of XEOMIN® (incobotulinumtoxinA) for the prevention of episodic and chronic migraine in adults. The trials recruited approximately 1800 adults across 109 study sites in North America and Europe. Migraine affects around 1.1 billion people worldwide, posing a significant burden on patients, society and healthcare systems.1 Both trials are evaluating the change in monthly migraine days from baseline to Month
Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation15.10.2026 07:10:00 CEST | Press release
Collaboration will connect seamless payments, in-app digital engagement and AI-powered travel services to enhance the visitor journey, empower businesses of all sizes and unlock wider cross-border commerce opportunities Tourism Malaysia and Alipay+, the unified wallet gateway of Ant International, today signed a Memorandum of Understanding (MoU) to accelerate cross-border commerce and digitalise merchant engagement across Malaysia's tourism economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014035900/en/ (From left) Mr Mohd Akbal Setia (Head of VM2026 Secretariat and Senior Director, Advertising & Digital Tourism); Mr Mohd Amirul Rizal Abdul Rahim (Director General, Tourism Malaysia); Mr Danny Chung (General Manager of Alipay+ Global Growth Center and Vice President of Ant International); Mr Michael Guo, Alipay+ General Manager of SEA, South Asia and ANZ, Ant International) As Malaysia welcomes visitors for Visit Mal
PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis15.10.2026 07:00:00 CEST | Press release
Patient-reported outcomes from a phase II study of nemolizumab in children aged 2 to 11 with moderate-to-severe atopic dermatitis show meaningful reductions in itch severity, better sleep and improved quality of life, maintained for a year1 Currently, there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis, despite the high unmet need – the disease can significantly reduce quality of life for children and create burden on their families2-8 These findings expand on the clinical evidence base for nemolizumab, which has multiple global approvals for adult and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis, and adults with prurigo nodularis9,10 Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of life in children aged 2 to 11 years with moderate-to-severe
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 02:30:00 CEST | Press release
− ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration (NMPA), the U.S. Food and Drug Administration (FDA) and Japan’s Ministry of Health, Labour and Welfare (MHLW) − Discovered by Takeda scientists in Japan, ORZEYFUL is the lead medicine in Takeda’s orexin franchise, with multiple programs for sleep-wake disorders and conditions where orexin biology plays a role − ORZEYFUL set to launch next month in the U.S., following completion of DEA scheduling; Health Authority submissions underway worldwide Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re ex
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
